Company Filing History:
9 out of 1,744 
3 out of 1,647 
1 out of 338 
Years Active: 1980-2009
Title: Pierre Corvol: Innovator in Hypertension Treatment
Introduction
Pierre Corvol is a prominent inventor based in Paris, France. He has made significant contributions to the field of medicine, particularly in the treatment of hypertension. With a total of 13 patents to his name, Corvol's work has had a substantial impact on medical research and pharmaceutical development.
Latest Patents
Among his latest patents are derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulfonates) and compositions comprising the same. This invention relates to derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulfonates) that are useful for the treatment and prevention of primary and secondary arterial hypertension. Another notable patent involves the bis-hydrochloride of 4,4'-dithiobis-(3-aminobutane-1-sodium sulphonate) and the bis-trifluoracetate of 4,4'-dithiobis-(3-aminobutane-1-sulphonate of 2,2-dimethylpropyl). This invention also includes a pharmaceutical composition comprising one of these compounds and its use in producing a medicament suitable for treating hypertension and related illnesses.
Career Highlights
Corvol has had a distinguished career, working with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the University of Utah Research Foundation. His research has focused on innovative solutions for managing hypertension, contributing to advancements in medical treatments.
Collaborations
Throughout his career, Corvol has collaborated with notable colleagues, including Florent Soubrier and Jean-Marc Lalouel. These partnerships have fostered a collaborative environment that has enhanced the quality and impact of his research.
Conclusion
Pierre Corvol's innovative work in the field of hypertension treatment has led to significant advancements in medical science. His numerous patents reflect his dedication to improving health outcomes for patients suffering from hypertension.